BinaryMint Ventures
Focuses on early-stage investments in next-gen B2B SaaS and cybersecurity solutions.
- SaaS
- Security
- Enterprise
Browse 7,562 venture capital firms headquartered in the USA. Median check across the 7393 firms that disclose a range is $500K–$2M; most active at Seed, Pre-Seed, Series A; concentrated in SaaS, AI / ML, Enterprise. Every firm is verified — explore their thesis, check size, and portfolio, then get matched with the best-fit investors for your startup.
Focuses on early-stage investments in next-gen B2B SaaS and cybersecurity solutions.
Investing in innovations at the intersection of AI and biotechnology that promise to enhance health diagnostics and treatment protocols.
Invests in early-stage life sciences companies with potential for high impact in health and biotechnology.
A rolling fund focused exclusively on seed-stage biotech startups in diverse geographies.
Focused on investing in early-stage startups innovating in lab automation and life science tools, with a particular interest in technologies that enhance research productivity.
Investing exclusively in healthcare and biotech innovations, with a focus on robotics and cloud-based tech for pharma and diagnostics.
Focuses on early-stage investments in breakthrough biological and computational technologies for healthcare.
Focused on synthetic biology, chemical-based innovations, and bioengineered material science solutions.
Focuses on early-stage investments in HealthTech and B2B SaaS companies that innovate the healthcare industry with AI solutions.
Midwest regional specialist backing bioscience startups from formation through seed, with strong ties to translational science, life sciences tools, and early company building. Often invests in scienc...
Dedicated to backing early-stage biotech and life sciences companies, with an emphasis on enabling technologies and tools for research and drug discovery.
Investing in biotech startups tackling significant industry hurdles using B2B SaaS models.
Focused on uncovering breakthrough Biotech startups solving critical industry challenges.
Invests in seed-stage health tech companies creating disruptive medical device solutions.
Focuses on funding innovative solutions that extend human health span and improve quality of life through wellness and biotechnologies.
Focusing solely on transformative MedTech and Biotech innovations with a focus on diagnostics and devices.
Focuses on early-stage companies with technology for biodiversity impact and sustainable practices.
Investing in Biotech firms creating next-gen tools for the pharmaceutical and agritech industries.
Focuses on seed investments in bioinformatics solutions transforming healthcare research and diagnostics.
Biolumina Ventures focuses on early-stage biotech startups that are leveraging cutting-edge AI and data analytics to transform drug discovery processes.
Focused exclusively on investing in startups that innovate with biomarkers to improve preventive health outcomes.
Focused on innovations in renewable biomanufacturing technologies and sustainable health solutions.
Invests in the earliest stages of HealthTech and MedTech, particularly those advancing care delivery efficiency.
Invests in AI and hardware innovations that enhance human-machine interactions through advanced biomechanics technologies.
Showing 889–912 of 7562 firms — page 38 of 316.